Release  date:  July 21, 2023 
  Expiration  date: July 20, 2026 
Estimated Time of Completion: 1 hour
		Description
        				Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
			  
	
		
Learning Objectives
	
    
	
	
    After  completing this case the reader should be able to:
    
  - Identify  the signs and symptoms of acute ischemic stroke. 
- Interpret  results from various acute ischemic stroke imaging technologies. 
- Compare  and contrast potential treatment options in the acute ischemic stroke setting. 
 
	 
 
	
		
Target Audience
	
	
	
		Directed to primary care physicians including family practitioners and internists.
 
	 
 
  
                
	
		
Accreditation
	
	
	
        
American  Medical Association (AMA)
  Cleveland  Clinic Center for Continuing Education designates this enduring activity for a  maximum of 1.0 AMA  PRA Category 1 Credits™. Physicians should claim only the credit  commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this  activity may submit the credit hours to the American Osteopathic Association  for Category 2 credit.
ABIM MOC:  Successful  completion of this CME activity, which includes participation in the evaluation  component, enables the participant to earn up to 1.0  Medical  Knowledge MOC points in the American Board of Internal Medicine's (ABIM)  Maintenance of Certification (MOC) program. It is the CME activity provider's  responsibility to submit participant completion information to ACCME for the  purpose of granting ABIM MOC credit.
    
  Your  credit will be reported to the ABIM within 30 days of claiming credit.  
ABA MOC: This activity contributes to the  CME component of the American Board of Anesthesiology’s redesigned Maintenance  of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA  2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA  2.0 requirements. 
  Maintenance  of Certification in AnesthesiologyTM program and MOCA® are  registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a  trademark of The American Board of Anesthesiology®.  
  Your  credit will be reported to the ABA within 30 days of claiming credit.  
ABS  MOC: This activity qualifies for 1.0  self-assessment  credits toward Part 2 of the American Board of Surgery (ABS) Maintenance of  Certification (MOC) Program. 
  Please  Note:  It is the participant’s responsibility to self-report their  participation to the American Board of Surgery, per board policy.  
        
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
        
        
         
	 
 
	
		
Activity Director and Faculty
	
	
	
    		Activity Directors
Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Medical Co-Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH
Steven Kawczak, PhD, CHCP, FACEHP
Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of CWRU
Co-Director, Center for Continuing Education
Staff, Center for Educational Resources
Education Institute
Cleveland Clinic
Cleveland, OH
        
   	Faculty
     
A  Blake Buletko, MD
  Cerebrovascular  Center
  Neurological  Institute
  Cleveland  Clinic
  Cleveland,  OH
    
        
	 
	 
 
	
		
CME Disclaimer
	
	
	
    	The information in this educational activity is provided for  general medical education purposes only and is not meant to substitute for the  independent medical judgment of a physician relative to diagnostic and  treatment options of a specific patient’s medical condition. The viewpoints expressed  in this CME activity are those of the authors/faculty. They do not represent an  endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland  Clinic Foundation be liable for any decision made or action taken in reliance  upon the information provided through this CME activity.
 
	 
 
Disclosures
	In accordance with the Standards for  Commercial Support issued by the Accreditation Council for Continuing Medical  Education (ACCME), The Cleveland Clinic Foundation Center for Continuing  Education requires resolution of all faculty conflicts of interest to ensure  CME activities are free of commercial bias.
    The  following faculty have indicated that he may have a relationship, which in the  context of his presentation(s), could be perceived as a potential conflict of  interest:
  
    | Anthony Fernandez, MD, PhD | 
  
    | Biogen Inc.,    Boehringer Ingelheim, Bristol-Myers Squibb Co., UCB, Inc. | Consulting | 
  
    | Pfizer, Inc. | Other    activities from which remuneration is received or expected: awarded a grant    to fund a medical dermatology fellowship positionResearch: PI
 | 
  
    | Kyowa Kirin,    Mallinckrodt Inc., Novartis | ConsultingTeaching and Speaking
 | 
  
    | Alexion | Research:    Principal Investigator | 
  
    | Abbvie Pharmaceuticals | ConsultingAdvisor or review panel participant
 Teaching and Speaking
 | 
                
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
A Blake Buletko, MD
Steven Kawczak, PhD
                
                
                
 
This CME activity was produced by The Cleveland Clinic Foundation 
  Center for Continuing Education.